Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Schmitz

Showing results (301-310 of 385) with videos related to

Pageof 39
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOPNorbert Schmitz, Samira Zeynalova, Maike Nickelsen, et al.
Blood|July 20, 2002
Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemiaNorbert Schmitz, Meral Beksac, Dirk Hasenclever, et al.
Lancet (London, England)|June 28, 2002
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trialNorbert Schmitz, Beate Pfistner, Michael Sextro, et al.
British Journal of Haematology|February 26, 2013
Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemiaBrigitte Mohr, Johannes Schetelig, Kerstin Schäfer-Eckart, et al.
Leukemia & Lymphoma|April 23, 2015
High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow TransplantationChristopher P Fox, Ariane Boumendil, Norbert Schmitz, et al.
Psychological Medicine|April 29, 2022
Manualized group cognitive behavioral therapy for social anxiety in first-episode psychosis: a randomized controlled trialMartin Lepage, Christopher R Bowie, Tina Montreuil, et al.
The Lancet. Oncology|November 22, 2012
Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)Norbert Schmitz, Maike Nickelsen, Marita Ziepert, et al.
Leukemia & Lymphoma|December 24, 2015
Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study GroupStephanie Sasse, Magdalena Alram, Horst Müller, et al.
Blood|June 6, 2009
Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow TransplantationAlexander Claviez, Carme Canals, Daan Dierickx, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2013
Hematopoietic stem cell transplantation in patients with lymphomatoid granulomatosis: a European group for blood and marrow transplantation reportKristina Siegloch, Norbert Schmitz, Huei-Shan Wu, et al.
Pageof 39

Showing results (301-310 of 385) with videos related to

Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOPNorbert Schmitz, Samira Zeynalova, Maike Nickelsen, et al.
Blood|July 20, 2002
Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemiaNorbert Schmitz, Meral Beksac, Dirk Hasenclever, et al.
Lancet (London, England)|June 28, 2002
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trialNorbert Schmitz, Beate Pfistner, Michael Sextro, et al.
British Journal of Haematology|February 26, 2013
Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemiaBrigitte Mohr, Johannes Schetelig, Kerstin Schäfer-Eckart, et al.
Leukemia & Lymphoma|April 23, 2015
High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow TransplantationChristopher P Fox, Ariane Boumendil, Norbert Schmitz, et al.
Psychological Medicine|April 29, 2022
Manualized group cognitive behavioral therapy for social anxiety in first-episode psychosis: a randomized controlled trialMartin Lepage, Christopher R Bowie, Tina Montreuil, et al.
The Lancet. Oncology|November 22, 2012
Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)Norbert Schmitz, Maike Nickelsen, Marita Ziepert, et al.
Leukemia & Lymphoma|December 24, 2015
Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study GroupStephanie Sasse, Magdalena Alram, Horst Müller, et al.
Blood|June 6, 2009
Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow TransplantationAlexander Claviez, Carme Canals, Daan Dierickx, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2013
Hematopoietic stem cell transplantation in patients with lymphomatoid granulomatosis: a European group for blood and marrow transplantation reportKristina Siegloch, Norbert Schmitz, Huei-Shan Wu, et al.
Pageof 39